title: Development of miliary tuberculosis related to anti-tumor necrosis factor-alpha inhibitor therapy for pustular psoriasis.
authors.forename: Monji
authors.initials: M
authors.lastname: Koga
authors.forename: Shiho
authors.initials: S
authors.lastname: Terawaki
authors.forename: Ryoko
authors.initials: R
authors.lastname: Tatsukawa
authors.forename: Masaki
authors.initials: M
authors.lastname: Fujita
authors.forename: Shinichi
authors.initials: S
authors.lastname: Imafuku
authors.forename: Juichiro
authors.initials: J
authors.lastname: Nakayama
mesh_terms: D000068879:Adalimumab; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy*; D014391:Tuberculosis, Miliary / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab